VHC Health & HealthTap: Reducing Patient Leakage & Boosting Experience

VHC Health & HealthTap Partnership Expands Access to On-Demand Urgent Care

Meta Description: VHC Health partners with HealthTap to provide 24/7 virtual urgent care, addressing care leakage and improving patient access.

American health systems are facing a growing challenge: engaging patients beyond customary hospital settings. Increasingly, individuals are turning to convenient options like payviders and retail healthcare clinics, a shift that disrupts continuity of care and threatens teh long-term viability of established healthcare providers. This trend, often referred to as care leakage, is prompting innovative solutions.

One such solution emerged recently with a strategic partnership in Virginia. VHC Health has joined forces with virtual physician practise HealthTap to significantly boost patient access to on-demand urgent care services. The collaboration allows VHC patients to connect with HealthTap physicians via video visits for diagnosis, treatment, and prescriptions for common conditions.

The core aim of this initiative is to expand convenient care options while simultaneously reducing needless visits to emergency departments, all while maintaining a cohesive patient experience. According to a company release, the service is designed to ensure continuity with VHC’s existing in-person providers.

“VHC Health is solving for 365-day access – filling the gap during evenings, weekends and holidays,” explained a senior official at HealthTap. “By integrating HealthTap, VHC extends its reach directly into the patient’s home, ensuring that when a patient needs care at an odd hour, they stay within the VHC ecosystem rather than leaking to a disjointed third party.”

Did you know? – Care leakage costs U.S. health systems billions annually. Convenient care options are driving this trend,as patients seek faster,more accessible services.

HealthTap is prioritizing a seamless and familiar experience for patients. Patients access the service directly through VHC’s existing digital platform.Should a patient require more comprehensive care, such as an X-ray or a specialist consultation, HealthTap physicians will digitally route the referral back to VHC’s network of providers.

A key element of the partnership is the integrated financial experience. Patients will pay their standard copay, mirroring the cost of an in-person VHC visit, as HealthTap’s billing system is fully integrated with VHC’s existing payer contracts, eliminating potential confusion regarding out-of-network expenses.

“Patients aren’t starting over with a stranger – they are accessing an extension of their medical home,” a company representative stated. “it’s the convenience of tech with the trust of their local system.” VHC represents HealthTap’s flagship health system partner utilizing this deep-integration model.

Pro tip – Deep integration,like that between VHC and HealthTap,is crucial for accomplished virtual care. It ensures a smooth patient experience and maintains continuity of care.

VHC CEO Chris Lane described the collaboration as a comprehensive effort to elevate the patient experience at his health system. He emphasized VHC’s dedication to increasing access to care and highlighted how the partnership establishes the necessary infrastructure for a more streamlined patient journey.

“With the future of healthcare increasingly centered on receiving high-quality services from the comfort of home, this collaboration enables patients to access urgent medical care virtually,” Lane remarked. “We specifically sought a partner that met the highest standards, including Joint Commission accreditation for telehealth.”

As the partnership progresses, VHC will closely monitor key metrics related to both patient and provider satisfaction to gauge its overall success. This data-driven approach w

Reader question – How might partnerships like this impact the role of primary care physicians in the future? What are your thoughts?

Worth a look

• Health Canada Approves Tenecteplase, First New Stroke Treatment in 27 Years
• Oxford Launches First Human Trial for Bundibugyo Ebola Vaccine